Abstract
The vitreous is involved in multiple diseases when an incomplete posterior vitreous detachment (PVD) occurs. An incomplete PVD can lead to several pathological conditions. Such visually threatening conditions are traditionally of exclusive surgical interest. In contrast, pharmacological vitreolysis is the effort to reduce or eliminate the pathogenetic role of the vitreous solely by means of drug delivery. Here we aim to review and summarize the evidence available to date about this challenging new approach.
Original language | English |
---|---|
Pages (from-to) | 179-185 |
Number of pages | 7 |
Journal | Ophthalmologica |
Volume | 230 |
Issue number | 4 |
DOIs | |
Publication status | Published - Nov 2013 |
Keywords
- Ocriplasmin
- Plasmin
- Vitreolysis
ASJC Scopus subject areas
- Ophthalmology
- Sensory Systems